Status:
COMPLETED
Cosopt Versus Xalatan
Lead Sponsor:
Pharmaceutical Research Network
Conditions:
Open-Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare the 24-hour efficacy and safety, measured every three hours, of the dorzolamide/timolol fixed combination given twice daily versus latanoprost and placebo each given once daily.
Eligibility Criteria
Inclusion
- adults with primary open-angle, pigmentary, or exfoliation glaucoma, or ocular hypertenstion
- intraocular pressure should be 22 to 30 mm Hg inclusive on timolol BID at the 08:00 H
- ETDRS visual acuity must be 1.0 or better in both eyes
Exclusion
- any contraindications to study medications
- any anticipated change in systemic hypertensive therapy during the trial
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00273429
Start Date
April 1 2005
End Date
December 1 2005
Last Update
January 9 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Florida Eye Associates
Lakeland, Florida, United States, 33805
2
Midwest Eye Center SC
Bourbonnais, Illinois, United States, 60914